How GLP-1 agonists help in type 2 diabetes
GLP-1 agonists such as semaglutide were developed for treatment of type II diabetes but have also been successful as weight-loss agents for non-diabetics. Many new agents are now in the pipeline. IMI spoke to Hannah Beba, Consultant Pharmacist in Diabetes, Leeds Health and Care Partnership to find out more. [embedded content] GLP-1 agonists mimic the action of the naturally-occurring incretin […]
Recent Comments